AVENUE THERAPEUTICS, INC.

Avenue Therapeutics (ATXI) has reported zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting operational stability in the near term. However, absence of recent events does not indicate absence of risk; a 90-day window captures only a narrow slice of the company's risk profile. The full $49 Report extends analysis across 12 months of filing history, applies dilution risk scoring, contextualizes historical 8-K activity, and surfaces AI-detected financing and balance-sheet signals that daily monitoring may miss. The full $49 Report adds comprehensive dilution trajectory analysis, 12-month red-flag context, and forward-risk signals grounded in capital structure trends.